ADIAL PHARMACEUTICALS INC (ADIL) Institutional Ownership and Insiders Activity
ADIAL PHARMACEUTICALS INC (ADIL) is widely held by institutional investors, with 16 firms reporting positions valued at approximately $334,199 based on SEC Form 13F filings for the quarter ended June 30, 2026.
Jane Street Group, Llc is the largest disclosed holder, reporting approximately $82,225 in ADIL holdings in its latest filing.
Recent insider activity includes 2 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
16
Total Reported Value
$334,199
Largest Holder
Jane Street Group, Llc
Largest Position
$82,225
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
4
Funds Exiting Positions
2
Top Institutional Owners
View allInvestorReported Balance
- Jane Street Group, Llc$82,225
- Citadel Advisors Llc$75,640
- China Universal Asset Management Co., Ltd.$53,120
- Ubs Group Ag$49,017
- Stonex Group Inc.$35,671
Related ADIL Institutional Insights:
- ADIL 13F Institutional Holders
- ADIL Superinvestors
- ADIL Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ADIL Insider Trading & SEC Form 4 Activity
- ADIL Articles
- Top Institutional Investor Stock Rankings